Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1760-1771

  Yang, Nianlan ^a,b   Zhang, Weixi ^a,c   Shi, Xing Ming ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Arthritis; COX 2; GILZ; Glucocorticoid; Mesenchymal stem cell

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 1BETA; LEUCINE ZIPPER PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; INTERLEUKIN-1BETA; LEUCINE ZIPPERS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROTEIN TRANSPORT; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41849146079     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21562     Document Type: Article

References (45)

1. Almawi WY, Melemedjian OK. 2002. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J Mol Endocrinol 28:69-78.
2. Arthaningtyas E, Kok CC, Mordvinov VA, Sanderson CJ. 2005. The conserved lymphokine element 0 is a powerful activator and target for corticosteroid inhibition in human interleukin-5 transcription. Growth Factors 23:211-221.
3. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. 1995. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
4. Ayroldi E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, Cannarile L, D'Adamio F, Riccardi C. 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98:743-753.
5. Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C. 2002. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 22:7929-7941.
6. Bazzy-Asaad A. 2001. Safety of inhaled corticosteroids in children with asthma. Curr Opin Pediatr 13:523-527.
7. Berrebi D, Bruscoli S, Cohen N, Foussat A, Migliorati G, Bouchet-Delbos L, Maillot MC, Portier A, Couderc J, Galanaud P, Peuchmaur M, Riccardi C, Emilie D. 2003. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: An anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101:729-738.
8. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H. 1996. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 271:19612-19616.
9. Buttgereit F, Straub RH, Wehling M, Burmester GR. 2004. Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action. Arthritis Rheum 50:3408-3417.
10. Cannarile L, Zollo O, D'Adamio F, Ayroldi E, Marchetti C, Tabilio A, Bruscoli S, Riccardi C. 2001. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ 8:201-203.
11. Cohen N, Mouly E, Hamdi H, Maillot MC, Pallardy M, Godot V, Capel F, Balian A, Naveau S, Galanaud P, Lemoine FM, Emilie D. 2005. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 2005-2007.
12. Conn DL. 2001. Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis. Arthritis Rheum 45:462-467.
13. Crofford LJ. 2000. The role of COX-2 in rheumatoid arthritis synovial tissues. Arthritis Res 1:S30.
14. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C. 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7:803-812.
15. Dayer JM. 2002. The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis. Joint Bone Spine 69:123-132.
16. De Bosscher K, Vanden Berghe W, Haegeman G. 2000. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 109:16-22.
17. De Bosscher K, Vanden Berghe W, Haegeman G. 2003. The interplay between the glucocorticoid receptor and nuclear factor-{kappa}B or activator protein-1: Molecular mechanisms for gene repression. Endocr Rev 24:488-522.
18. Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, Zuraw BL. 2007. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119:115-122.
19. Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature 423:356-361.
20. Fitzpatrick FA. 2004. Cyclooxygenase enzymes: Regulation and function. Curr Pharm Des 10:577-588.
21. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. 1997. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 16:4698-4707.
22. Hinz B, Brune K. 2002. Cyclooxygenase-2-10 years later. J Pharmacol Exp Ther 300:367-375.
23. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D. 2004. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50:817-827.
24. Jorgensen C, Noel D, Gross G. 2002. Could inflammatory arthritis be triggered by progenitor cells in the joints? Ann Rheum Dis 61:6-9.
25. Jorgensen C, Gordeladze J, Noel D. 2004. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 15:406-410.
26. Kirwan JR. 2000. Effects of long-term glucocorticoid therapy in rheumatoid arthritis. Z Rheumatol 59II/85-11:89.
27. Li X, Makarov SS. 2006. An essential role of NF-{kappa}B in the "tumor-like" phenotype of arthritic synoviocytes. Proc Natl Acad Sci 103:17432-17437.
28. Lukert BP, Raisz LG. 1990. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112:352-364.
29. Mestre JR, Rivadeneira DE, Mackrell PJ, Duff M, Stapleton PP, Mack-Strong V, Maddali S, Smyth GP, Tanabe T, Daly JM. 2001. Overlapping CRE and E-box promoter elements can independently regulate COX-2 gene transcription in macrophages. FEBS Lett 496:147-151.
30. Mittelstadt PR, Ashwell JD. 2001. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276:29603-29610.
31. Morisset S, Patry C, Lora M, Brum-Fernandes AJ. 1998. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin lalpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol. J Rheumatol 25:1146-1153.
32. Newton R, Kuitert LM, Slater DM, Adcock IM, Barnes PJ. 1997. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 60:67-78.
33. Okada Y, Voznesensky O, Herschman H, Harrison J, Pilbeam C. 2000. Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells. J Cell Biochem 78:197-209.
34. Ory DS, Neugeboren BA, Mulligan RC. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 93:11400-11406.
35. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:45.
36. Ray A, Prefontaine KE. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756.
37. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interferenc. Nat Genet 33:401-406.
38. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS, Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
39. Shi X, Shi W, Li Q, Song B, Wan M, Bai S, Cao X. 2003. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep 4:374-380.
40. Shibanuma M, Kuroki T, Nose K. 1992. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J Biol Chem 267:10219-10224.
41. Tak PP, Firestein GS. 2001. NF-kappaB: A key role in inflammatory diseases. J Clin Invest 107:7-11.
42. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW. 2002. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects: A randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136:1-12.
43. Wadleigh DJ, Herschman HR. 1999. Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. Biochem Biophys Res Commun 264:865-870.
44. Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. 2000. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 275:6259-6266.
45. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.